Malaria vaccines-targeting infected hepatocytes

Nature Medicine

Volumn 6, Issue 11, 2000, Pages 1218-1219

  Hoffman, Stephen L ^a   Doolan, Denise L ^a,b  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MALARIA VACCINE; NITRIC OXIDE; PARASITE ANTIGEN; STAT PROTEIN;

CHIMPANZEE; DRUG EFFICACY; EPITOPE MAPPING; HOST RESISTANCE; HUMAN; IMMUNOGENICITY; LIVER CELL; MALARIA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SPOROZOITE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ANOPHELES; FEMALE; HEPATOCYTES; HUMANS; INSECT BITES AND STINGS; MALARIA VACCINES; MALARIA, FALCIPARUM; PAN TROGLODYTES; PLASMODIUM FALCIPARUM;

PAN (APE); PAN TROGLODYTES;

EID: 0033693818     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/81315     Document Type: Short Survey

References (17)

1. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with a conserved pre-erythrocyte antigen, LSA- 3
2. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei
3. Immunization of man against sporozoite-induced falciparum malaria
4. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria
5. The complexity of protective immunity against liver-stage malaria
6. Attacking the infected hepatocyte
7. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group
8. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3
9. Long-term efficacy and immune responses following immunization with the RTS,S Malaria vaccine
10. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS 2, a recombinant Plasmodium falciparum malaria vaccine
11. Intramuscular administration of a malaria DNA vaccine is safe, well-tolerated and induces CTL, but not detectable antibodies, in healthy human volunteers
12. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
13. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
14. A protein particle vaccine containing multiple malaria epitopes
15. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum
16. From genomics to vaccines: Malaria as a model system
17. Research toward vaccines against malaria